Cambridge Bioscience partners with AAT Bioquest

Cambridge Bioscience is delighted to announce a new strategic distribution partnership with AAT Bioquest, following our recent acquisition of Stratech Scientific.  This extends the availability of AAT Bioquest’s high-performance bioreagent solutions for life science, diagnostic R&D and drug discovery researchers across the UK and Ireland

The partnership will provide scientists with streamlined access to AAT Bioquest’s extensive portfolio of products, including reactive fluorescent and luminescent probes, biotins, tag enzymes and assay development reagents, alongside custom services designed to support applications in biochemistry, immunology, cell biology and molecular biology

AAT Bioquest is a US-based bioreagents company specialising in assay technologies and photometric detection solutions, including fluorescence, luminescence and colorimetric technologies.  The company is recognised for developing innovative, high-quality reagents, probes and assay kits that help researchers address complex challenges in life science research, diagnostic R&D and drug discovery.

Through this partnership, Cambridge Bioscience will provide local technical support, product expertise and customer service, ensuring researchers across the UK and Ireland can fully leverage AAT Bioquest’s trusted portfolio and custom capabilities to advance their scientific discoveries.

This collaboration further strengthens Cambridge Bioscience’s commitment to supporting the UK and Ireland life science community with high-quality tools and technologies that accelerate research, innovation and discovery.

Learn more about AAT Bioquest’s portfolio or contact our Bioquest specialists.